Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
Clinical trial NCT00420238 · COMPLETED
Trial details
- NCT number
- NCT00420238
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2009-02-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.